Compare GBCI & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GBCI | BCPC |
|---|---|---|
| Founded | 1955 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 5.8B |
| IPO Year | 1996 | 1995 |
| Metric | GBCI | BCPC |
|---|---|---|
| Price | $44.79 | $170.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $53.60 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 970.0K | 142.1K |
| Earning Date | 04-23-2026 | 05-25-2026 |
| Dividend Yield | ★ 2.94% | 0.56% |
| EPS Growth | 18.45 | ★ 20.87 |
| EPS | 1.99 | ★ 4.75 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | $31.62 | $8.28 |
| Revenue Next Year | $8.37 | $4.90 |
| P/E Ratio | ★ $22.58 | $35.98 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $36.76 | $139.17 |
| 52 Week High | $53.99 | $183.90 |
| Indicator | GBCI | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 42.64 |
| Support Level | $43.01 | $165.89 |
| Resistance Level | $46.61 | $183.45 |
| Average True Range (ATR) | 1.62 | 5.20 |
| MACD | -0.44 | -1.57 |
| Stochastic Oscillator | 30.73 | 21.60 |
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.